Salt Lake City, Ut., USA - December 17, 2014, Salt Lake City, Ut., USA - Great Basin Scientific, Inc., a molecular diagnostics company, welcomed Ronald K. Labrum and Sam Chawla to its board of directors, effective October 9, 2014.
Article continues below
Both Mr. Labrum and Mr. Chawla will serve as independent directors at Great Basin Scientific,
Inc.
Mr. Labrum serves as Chairman of Suture Express, Inc., a wound care supply distribution company, and as independent director at Wright Medical Group. Mr. Labrum is also on the board of Ortho Clinical Diagnostics and served on the board of Aptalis Pharma, Inc., which was acquired by Forest Laboratories in early 2014.
He has more than 30 years of operating experience in the medical technology and supplies industry, including serving as President and Chief Executive Officer of Fenwal, Inc., a U.S.-based provider of transfusion technology products for blood collection, separation and processing prior to its acquisition by Fresenius Kabi in 2012.
Mr. Labrum was also Chief Executive Officer of Cardinal Healthcare Supply Chain Services, a subsidiary of Cardinal Health, President of Allegiance Manufacturing & Distribution and Allegiance Healthcare Corp., both subsidiaries of American Hospital Supply Corp., and Baxter International, Inc. He received his undergraduate degree from Utah State University.
Mr. Chawla is a Portfolio Manager at Perceptive Advisors LLC, a dedicated healthcare
investment fund. He is also on the board of directors at Response Genetics, Inc., a molecular
diagnostics company focused on oncology, and VBI Vaccines, Inc., a biopharmaceutical
company developing novel vaccine-based therapeutics.
Prior to joining Perceptive Advisors in August 2013, Mr. Chawla was a Managing Director of the Healthcare Investment Banking Group at UBS Securities LLC. Mr. Chawla has been a senior advisor on numerous strategic mergers and acquisitions (M&A) transactions and equity and debt financings in the diagnostics and medical technology sectors. ■